India to Guinea: Spironolactone Export Trade Route

The India to Guinea Spironolactone corridor is one of India's established pharmaceutical export routes, with 37 shipments documented worth a combined $638.9K USD. The route is dominated by ATOZ PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's spironolactone manufacturing sector.

Across 14 active suppliers, the average shipment value stands at $17.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with spironolactone's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.0%, placing it at rank #18 among India's top spironolactone export destinations globally.

On the import side, key buyers of Indian spironolactone in Guinea include SOGUIPREM SARL, MSSOGUIPREM SARL, TO THE ORDER and 17 others. SOGUIPREM SARL is the single largest importer with 3 shipments valued at $551.3K USD.

India's spironolactone exports to Guinea are driven primarily by a handful of large-scale manufacturers. ATOZ PHARMACEUTICALS PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Guinea benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ATOZ PHARMACEUTICALS PRIVATE LIMITED, ATOZ PHARMACEUTICALS PVT LTD, MERIT ORGANICS LIMITED — together account for 95% of total trade value on this route. The average shipment value of $17.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as spironolactone 50 mg+hydrochlorothiazide25 mg tablet b.no.gu 27 302 manufacturing .dt.07/2023 exp.dt.06/2025 atolactazide and pharmaceutical formulation for human use: spironolactone tablets bp 25mg, suggesting that buyers in Guinea tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SOGUIPREM SARL is the largest importer with 3 shipments worth $551.3K USD — representing 86% of all spironolactone imports from India on this route. A total of 20 buyers are active on this corridor.